(Q46604884)

23 December 2017

title

Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation (English)

1 reference

23 December 2017

1

Gary E Swan

1 reference

23 December 2017

Lisa M. Jack

2

object named as

Lisa M Jack

1 reference

23 December 2017

Jennifer B McClure

5

object named as

Jennifer B McClure

1 reference

23 December 2017

author name string

Harold S Javitz

3

1 reference

23 December 2017

Tim McAfee

4

1 reference

23 December 2017

publication date

1 January 2008

1 reference

23 December 2017

published in

CNS Drugs

1 reference

23 December 2017

volume

22

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

239-256

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.2165/00023210-200822030-00004

exact match

0 references

cites work

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200822030-00004

Measures of abstinence in clinical trials: issues and recommendations

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200822030-00004

Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200822030-00004

Cigarette smoking among adults--United States, 1999

21 January 2018

1 reference

12 December 2020

Relapse and maintenance issues for smoking cessation

1 reference

12 December 2020

Biochemical verification of tobacco use and cessation

1 reference

12 December 2020

Use of the current population survey to characterize subpopulations of continued smokers: a national perspective on the "hardcore" smoker phenomenon

1 reference

12 December 2020

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo

1 reference

12 December 2020

Compliance with antidepressant therapy and antidepressant discontinuation symptoms

1 reference

12 December 2020

How important are gender differences in pharmacokinetics?

1 reference

12 December 2020

Biochemical validation of smoking status: pros, cons, and data from four low-intensity intervention trials.

1 reference

12 December 2020

Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression

1 reference

12 December 2020

Interventions for enhancing medication adherence

1 reference

12 December 2020

Psychological intervention and antidepressant treatment in smoking cessation

1 reference

12 December 2020

Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects

1 reference

12 December 2020

Relapse prevention for smoking cessation: review and evaluation of concepts and interventions

1 reference

12 December 2020

Influence of antidepressant pharmacotherapy on behavioral treatment adherence and smoking cessation outcome in a combined treatment involving fluoxetine

1 reference

12 December 2020

The role of tobacco intervention in population-based health care: a case study

1 reference

12 December 2020

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

1 reference

12 December 2020

Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial

1 reference

12 December 2020

Repeated split sample validation to assess logistic regression and recursive partitioning: an application to the prediction of cognitive impairment

1 reference

12 December 2020

A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.

1 reference

12 December 2020

Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling

1 reference

12 December 2020

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

1 reference

12 December 2020

The validity of self-reported smoking: a review and meta-analysis

1 reference

12 December 2020

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

1 reference

12 December 2020

Impact of medication nonadherence on coronary heart disease outcomes. A critical review

1 reference

12 December 2020

The effect of bupropion sustained-release on cigarette craving after smoking cessation

1 reference

12 December 2020

Risk classification after aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study.

1 reference

12 December 2020

Compliance, adherence, and concordance: implications for asthma treatment

1 reference

12 December 2020

Methods to improve medication adherence in patients with hypertension: current status and future directions

1 reference

12 December 2020

Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism

1 reference

12 December 2020

Pharmacogenomics: marshalling the human genome to individualise drug therapy

1 reference

12 December 2020

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

1 reference

12 December 2020

Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness

1 reference

12 December 2020

Pharmacoeconomic impact of non-compliance with statins

1 reference

12 December 2020

Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome

1 reference

12 December 2020

Predictors of smoking cessation among elderly smokers treated for nicotine dependence

1 reference

12 December 2020

Subgroups of smokers with different success rates after use of transdermal nicotine.

1 reference

12 December 2020

Adverse events, compliance, and changes in therapy

1 reference

12 December 2020

Smoking behaviors and regular source of health care among African Americans

1 reference

12 December 2020

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

12 December 2020

Nicodermal patch adherence and its correlates.

1 reference

12 December 2020

Bupropion SR and smoking cessation in actual practice: methods for recruitment, screening, and exclusion for a field trial in a managed-care setting

1 reference

12 December 2020

A psychosocial model of smoking cessation and maintenance of cessation

1 reference

12 December 2020

Self-help quit smoking interventions: effects of self-help materials, social support instructions, and telephone counseling.

1 reference

12 December 2020

Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective.

1 reference

12 December 2020

Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications

1 reference

12 December 2020

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation

1 reference

12 December 2020

Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer's perspective

1 reference

12 December 2020

Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial

1 reference

12 December 2020

10.2165/00023210-200822030-00004

Identifiers

DOI

1 reference

23 December 2017

Dimensions Publication ID

1023900871

0 references

1 reference

23 December 2017